High frequency of down-regulation of E-cadherin detected in benign sporadic insulinomas by multiplex ligation-dependent probe amplification

Human Pathology

Volumn 40, Issue 9, 2009, Pages 1336-1341

  Jia, HuiYing ^a   Jiang, XiaoHua ^a   Zhao, ZeFei ^a,b   Ge, Yan ^a   Lu, JieLi ^a   Zhao, YongJu ^a   Cui, Bin ^a,b   Ning, Guang ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES   (China)

Author keywords

catenin; CDH1; E cadherin; Multiplex ligation dependent probe amplification (MLPA); Sporadic insulinomas

Indexed keywords

BETA CATENIN; UVOMORULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GENE INACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INSULINOMA; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; BETA CATENIN; CADHERINS; CHROMOSOMES, HUMAN, PAIR 16; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULINOMA; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PANCREATIC NEOPLASMS; YOUNG ADULT;

EID: 68549117133     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.03.002     Document Type: Article

References (33)

1. Jonkers Y.M., Claessen S.M., Perren A., et al. Chromosomal instability predicts metastatic disease in patients with insulinomas. Endocr Relat Cancer 12 (2005) 435-447
2. Jonkers Y.M., Claessen S.M., Feuth T., et al. Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis. J Pathol 210 (2006) 450-458
3. Pelengaris S., and Khan M. Oncogenic co-operation in beta-cell tumorigenesis. Endocr Relat Cancer 8 (2001) 307-314
4. Portela-Gomes G.M., Stridsberg M., Grimelius L., et al. Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas-predominance of receptor subtype 4. Endocr Pathol 18 (2007) 79-85
5. Jensen R.T. Pancreatic endocrine tumors: recent advances. Ann Oncol 10 (1999) S170-S176
6. Gumbs A.A., Moore P.S., Falconi M., et al. Review of the clinical, histological, and molecular aspect of pancreatic endocrine neoplasms. J Surg Oncol 81 (2002) 45-54
7. Wilder R.D., Allan F.N., and Power N.H. Carcinoma of islands of pancreas, hyperinsulinism and hypoglycemia. JAMA 89 (1927) 348
8. Jonkers Y.M., Ramaekers F.C., and Speel E.J. Molecular alterations during insulinoma tumorigenesis. Biochim Biophys Acta 1775 (2007) 313-332
9. Schouten J.P., McElgunn C.J., Waaijer R., et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30 (2002) e57
10. González J.R., Carrasco J.L., Armengol L., et al. Probe-specific mixed-model approach to detect copy number differences using multiplex ligation-dependent probe amplification (MLPA). BMC Bioinformatics 9 (2008) 261
11. Hogervorst F.B., Nederlof P.M., Gille J.J., et al. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Research 63 (2003) 1449-1453
12. Bremmer J.F., Braakhuis B.J., Ruijter-Schippers H.J., et al. A noninvasive genetic screening test to detect oral preneoplastic lesions. Lab Invest 85 (2005) 1481-1488
13. Van Dijk M.C., Rombout P.D., Boots-Sprenger S.H., et al. Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue. Diagnostic Molecular Pathology 14 (2005) 9-16
14. Postma C., Hermsen M.A., Coffa J., et al. Chromosomal instability in flat adenomas and carcinomas of the colon. Journal of Pathology 205 (2005) 514-521
15. Kuzin N.M., Egorov A.V., Kondrashin S.A., et al. Preoperative and intraoperative topographic diagnosis of insulinomas. World J Surg 22 (1998) 593-597
16. Grant C.S. Surgical aspects of hyperinsulinemic hypoglycemia. Endocrinol Metab Clin North Am 28 (1999) 533-554
17. Komminoth P., Perren A., Öberg K., et al. Insulinoma. In: DeLellis R.A., Lloyd R.V., Heitz P.U., and Eng C. (Eds). Pathology and genetics. Tumours of endocrine organs (2004), IARC Press, Lyon 183-186
18. Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem 59 (1990) 237-252
19. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153 (1998) 333-339
20. Christofori G., and Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24 (1999) 73-76
21. Perez-Moreno M., Jamora C., and Fuchs E. Sticky business: orchestrating cellular signals at adherens junctions. Cell 112 (2003) 535-548
22. Kobielak A., and Fuchs E. Alpha-catenin: at the junction of intercellular adhesion and actin dynamics. Nat Rev Mol Cell Biol 5 (2004) 614-625
23. Behrens J., von Kries J.P., Kühl M., et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382 (1996) 638-642
24. Rubinfeld B., Souza B., Albert I., et al. Association of the APC gene product with beta-catenin. Science 262 (1993) 1731-1734
25. Willert K., and Nusse R. β-Catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 8 (1998) 95-102
26. Molenaar M., van de Wetering M., Oosterwegel M., et al. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86 (1996) 391-399
27. Krieghoff E., Behrens J., and Mayr B. Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. J Cell Sci 119 (2006) 1453-1463
28. Guilford P., Hopkins J., Harraway J., et al. E-cadherin germline mutations in familial gastric cancer. Nature 392 (1998) 402-405
29. Gumbiner B.M. A balance between B-catenin and APC. Curr Biol 7 (1997) R443-R446
30. Dahl U., Sjødin A., and Semb H. Cadherins regulate aggregation of pancreatic beta-cells in vivo. Development 122 (1996) 2895-2902
31. Yamagata K., Nammo T., Moriwaki M., et al. Overexpression of dominant-negative mutant hepatocyte nuclear factor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes. Diabetes 51 (2002) 114-123
32. Carvell M.J., Marsh P.J., Persaud S.J., et al. E-cadherin interactions regulate beta-cell proliferation in islet-like structures. Cell Physiol Biochem 20 (2007) 617-626
33. Chetty R., Serra S., and Asa S.L. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors. Am J Surg Pathol 32 (2008) 413-419